MedPath

Normative Values Laser Nociceptive Evoked Potentials Depending on the Age

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: laser stimulations on lower limbs
Device: laser stimulations cervical
Device: 20 laser stimulations for each site on the upper limbs
Device: laser stimulations on face and neck
Registration Number
NCT02531048
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Different neurological damage may alter the pain conduction systems centrally (spinothalamic pathway) or peripherally (small caliber sensory fibers A delta and C). The laser thermal stimulation selectively stimulates the pain pathways and generates nociceptive signals conveyed to the cortex. Registering these cortical responses constitute the technical laser nociceptive evoked potentials. If these tests are routinely used, their interpretation must remain cautious especially in the elderly.

Detailed Description

Different neurological damage may alter the pain conduction systems centrally (spinothalamic pathway) or peripherally (small caliber sensory fibers A delta and C). The laser thermal stimulation selectively stimulates the pain pathways and generates nociceptive signals conveyed to the cortex. Registering these cortical responses constitute the technical laser nociceptive evoked potentials. If these tests are routinely used, their interpretation must remain cautious especially in the elderly. Normal values that are available have been obtained in young subjects. However, various studies have shown that the integration of nociceptive messages depended on age. The aim of this study was to establish normal values of nociceptive evoked potentials for each age group of 18 to 75 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • major
Exclusion Criteria
  • Neurological history
  • Neuralgia history (> 3 months)
  • Pathology can cause neuropathy (unbalanced thyroid dysfunction, diabetes, kidney failure, chronic hepatitis, HIV ...)
  • Dermatological disorder known type of Lucite or photosensitivity
  • Medical treatment analgesic, psychotropic or anti-epileptic underway
  • Toxic acquired in the last 72 hours (alcohol, cannabis, other toxic ...)
  • Pregnant women
  • Incapacitate to stand still
  • Participation in another biomedical research in the field of pain in the three months prior to inclusion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
healthy volunteerslaser stimulations cervicalHealthy volunteers are able to participate to this study. They must not have neurological troubles. They will have different stimulations : * laser stimulations on lower limbs * laser stimulations cervical * 20 laser stimulations for each site on the upper limbs * laser stimulations on face and neck
healthy volunteerslaser stimulations on lower limbsHealthy volunteers are able to participate to this study. They must not have neurological troubles. They will have different stimulations : * laser stimulations on lower limbs * laser stimulations cervical * 20 laser stimulations for each site on the upper limbs * laser stimulations on face and neck
healthy volunteers20 laser stimulations for each site on the upper limbsHealthy volunteers are able to participate to this study. They must not have neurological troubles. They will have different stimulations : * laser stimulations on lower limbs * laser stimulations cervical * 20 laser stimulations for each site on the upper limbs * laser stimulations on face and neck
healthy volunteerslaser stimulations on face and neckHealthy volunteers are able to participate to this study. They must not have neurological troubles. They will have different stimulations : * laser stimulations on lower limbs * laser stimulations cervical * 20 laser stimulations for each site on the upper limbs * laser stimulations on face and neck
Primary Outcome Measures
NameTimeMethod
composite outcomes : latencies (ms) and amplitudes (μV) of nociceptive evoked potentialDay 0
Secondary Outcome Measures
NameTimeMethod
detection threshold (mJ/mm2)Day 0
nociceptive threshold (mJ/mm2)day 0

Trial Locations

Locations (1)

Chu de Saint Etienne

🇫🇷

Saint Etienne, France

© Copyright 2025. All Rights Reserved by MedPath